Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GERN - Geron Corporation
362 M
LAST VALUE
173.05%
2 YEAR CAGR
31.24%
5 YEAR CAGR
49.36%
10 YEAR CAGR